Literature DB >> 16962927

Antioxidant and cytoprotective properties of high-density lipoproteins in vascular cells.

Anne Negre-Salvayre1, Nicole Dousset, Gianna Ferretti, Tiziana Bacchetti, Giovanna Curatola, Robert Salvayre.   

Abstract

Beside their key role in the regulation of cholesterol homeostasis, HDL exhibit antioxidant and anti-inflammatory properties that participate to their general antiatherogenic effect. The purpose of this review is to summarize the recent findings on antioxidant activity and cytoprotective cell signalling elicited by HDL against oxidized LDL and proatherogenic agents in vascular cells. HDL exhibit an antioxidant activity efficient to prevent LDL oxidation, or to inactivate newly formed lipid oxidation products. The antioxidant ability of HDL is due to the apoprotein moiety and to the presence of associated enzymes, paraoxonase and PAF-Acetyl Hydrolase. HDL prevent the intracellular oxidative stress and the inflammatory response elicited by oxidized LDL (ox-LDL), by inhibiting the NFkappaB signalling pathway, and the subsequent inflammatory events (expression of adhesion molecules, recruitment and proliferation of mononuclear cells within the vascular wall). HDL prevent ox-LDL-mediated cell activation and proliferation, this being also attributed to the presence in HDL of sphingosine-1 phosphate which modulates the migration and survival of vascular cells. Lastly, HDL inhibit apoptosis elicited by ox-LDL in vascular cells. Recent evidences indicate that, beside their strong antiatherogenic properties, HDL could exert their protective effect in diseases generally associated to inflammatory events.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16962927     DOI: 10.1016/j.freeradbiomed.2006.07.006

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  32 in total

1.  HDLs inhibit endoplasmic reticulum stress and autophagic response induced by oxidized LDLs.

Authors:  C Muller; R Salvayre; A Nègre-Salvayre; C Vindis
Journal:  Cell Death Differ       Date:  2010-11-26       Impact factor: 15.828

2.  Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure.

Authors:  Guoqing Cao; Thomas P Beyer; Youyan Zhang; Robert J Schmidt; Yan Q Chen; Sandra L Cockerham; Karen M Zimmerman; Sotirios K Karathanasis; Ellen A Cannady; Todd Fields; Nathan B Mantlo
Journal:  J Lipid Res       Date:  2011-09-25       Impact factor: 5.922

3.  Association between high-density lipoprotein cholesterol level and risk of hematologic malignancy.

Authors:  Su-Min Jeong; Taewoong Choi; Dahye Kim; Kyungdo Han; Seok Jin Kim; Sang Youl Rhee; Edward L Giovannucci; Dong Wook Shin
Journal:  Leukemia       Date:  2020-12-02       Impact factor: 11.528

4.  Influence of Fatty Acid Modification on Uptake of Lovastatin-Loaded Reconstituted High Density Lipoprotein by Foam Cells.

Authors:  Yun Yang; Ji Wang; Hongliang He; Wenli Zhang; Yuansheng Zhang; Jianping Liu
Journal:  Pharm Res       Date:  2018-05-07       Impact factor: 4.200

Review 5.  The metabolism and anti-atherogenic properties of HDL.

Authors:  Kerry-Anne Rye; Christina A Bursill; Gilles Lambert; Fatiha Tabet; Philip J Barter
Journal:  J Lipid Res       Date:  2008-11-24       Impact factor: 5.922

6.  Role of sphingosine 1-phosphate in anti-atherogenic actions of high-density lipoprotein.

Authors:  Koichi Sato; Fumikazu Okajima
Journal:  World J Biol Chem       Date:  2010-11-26

Review 7.  High-density lipoprotein and atherosclerosis: the role of antioxidant activity.

Authors:  Salman Bandeali; John Farmer
Journal:  Curr Atheroscler Rep       Date:  2012-04       Impact factor: 5.113

8.  Variability in follicular fluid high density lipoprotein particle components measured in ipsilateral follicles.

Authors:  Keewan Kim; Michael S Bloom; Victor Y Fujimoto; Erin M Bell; Recai M Yucel; Richard W Browne
Journal:  J Assist Reprod Genet       Date:  2016-01-12       Impact factor: 3.412

Review 9.  Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome.

Authors:  Paul R J Ames; Annamaria Margarita; Jose Delgado Alves
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

10.  Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment.

Authors:  Judit Marsillach; Gerard Aragonès; Bharti Mackness; Michael Mackness; Anna Rull; Raúl Beltrán-Debón; Juan Pedro-Botet; Carlos Alonso-Villaverde; Jorge Joven; Jordi Camps
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.